K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
Business Model:
Revenue: $0
Employees: 1-10
Address: 1 Main Street
City: Cambridge
State: MA
Zip: 02142
Country: US
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2023 | Series B | $0 |
Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest |
12/2021 | Series A | 3 | $30M |
Atlas Venture Eight Roads Ventures F-Prime Capital Atlas Venture Eight Roads Ventures F-Prime Capital |
6/2023 | Series B | 5 | $70M |
Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest Atlas Venture Bristol Myers Squibb Eight Roads Ventures F-Prime Capital Nextech Invest |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|